Results 131 to 140 of about 441,361 (298)

Transfemoral Transcatheter Aortic Valve Implantation (TF‐TAVI) for Patients With Left Ventricular Assist Device (LVAD) and Aortic Regurgitation

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Aortic regurgitation (AR) develops in up to 25%−30% of patients with left ventricular assist device (LVAD). Treatment remains challenging since surgery confers significant peri‐operative risk and the lack of valvular calcification renders transfemoral transcatheter aortic valve implantation (TF‐TAVI) with non‐dedicated devices technically ...
Daniel Tai‐Leung Chan, Ho‐On Alston Conrad Chiu, Ka‐Lam Wong, Ka‐Chun Un, Kwong‐Yue Eric Chan, Shu‐Yue Sze, Chor‐Cheung Frankie Tam, On‐Yat Wong, Gilbert H. L. Tang, Simon Cheung‐Chi Lam   +9 more
wiley   +1 more source

Enhancing explainability in clinical deep-learning models: Latent-space variable decoding is superior to gradient-weighted class activation mapping

Heart Rhythm O2
Background: Deep-learning models designed to assist with clinical decision making abound in cardiology. However, the “black box” nature of these models limits physicians’ ability to use them to cross-check clinical gestalt when evaluating model ...
Richard T. Carrick, MD, PhD, Ethan J. Rowin, MD, Alessio Gasperetti, MD, PhD, Christopher Madias, MD, Martin Maron, MD, Katherine C. Wu, MD   +5 more
doaj   +1 more source

Evaluating the Utility of a New Pathogenicity Predictor for Pediatric Cardiomyopathy [PDF]

, 2023
Alyssa L. Rippert, Sarah Trackman, Danielle S. Burstein, J. William Gaynor, Heather Griffis, Christine Seymour, Rebecca C. Ahrens‐Nicklas   +6 more
openalex   +1 more source

Left Ventricular Apical Thrombus in Apical Hypertrophic Cardiomyopathy Without Aneurysm or Arrhythmia: A Case Report

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Apical hypertrophic cardiomyopathy (ApHCM) is a rare variant of hypertrophic cardiomyopathy, typically associated with a benign course. However, complications such as ventricular arrhythmias, apical aneurysms, and thrombus formation may occur. Left ventricular (LV) thrombus is an unusual finding in ApHCM, especially in patients with preserved ...
Ibrahim Antoun, Jeffrey Khoo, Sanjay S. Bhandari   +2 more
wiley   +1 more source

Screening for mutations in human cardiomyopathy- is RBM24 a new but rare disease gene? [PDF]

, 2018
Anna Gaertner, Andreas Brodehl, Hendrik Milting   +2 more
openalex   +1 more source

A rare case of permanent pacemaker-induced takotsubo cardiomyopathy in a male patient

, 2022
Imran Moinudddin, Ibrar Anjum, Umer Zia, Muhammad Bila Zia, Sajid Ali   +4 more
openalex   +1 more source

Percutaneous Management of Right Ventricular Outflow Tract Obstruction in an Adult Patient After Atrial Switch: A Case for Targeted Infundibular Ablation

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Alcohol septal ablation is a well‐established treatment method for patients with hypertrophic cardiomyopathy. We present a case report of a patient with transposition of the great arteries (TGA) after a Mustard procedure, who developed significant right ventricular outflow tract obstruction (RVOTO), functionally resembling subaortic stenosis ...
Vera Osberghaus, Kerstin Wustmann, Pinar Bambul Heck, Stanimir Georgiev, Andreas Eicken, Peter Ewert, Katarzyna Gendera   +6 more
wiley   +1 more source

Obstructive Hypertrophic Cardiomyopathy and Aortic Stenosis With High Surgical Risk

JACC: Case Reports
Background: Treatment and accurate assessment of aortic valve stenosis (AS) with concomitant obstructive hypertrophic cardiomyopathy (HCM) prove challenging.
Omar M. Abdelfattah, MD, Robyn Bryde, MD, Kutaiba Nazif, MD, Matthew W. Martinez, MD   +3 more
doaj   +1 more source

Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Proposed Modification of the Task Force Criteria

European Heart Journal, 2010
F. Marcus, W. J. McKenna, D. Sherrill, C. Basso, B. Bauce, D. A. Bluemke, H. Calkins, D. Corrado, M. Cox, James P. Daubert, G. Fontaine, K. Gear, R. Hauer, A. Nava, Michael H. Picard, N. Protonotarios, J. Saffitz, Danita M. Yoerger Sanborn, Jonathan S. Steinberg, H. Tandri, G. Thiene, J. Towbin, A. Tsatsopoulou, T. Wichter, W. Zareba   +24 more
semanticscholar   +1 more source

Evolving Real‐World Data and Evidence Use for New Drugs and Regenerative Medical Products Approvals in Japan—An Analysis of the 6‐Year Trend

Clinical Pharmacology &Therapeutics, EarlyView.
Several regulatory initiatives have been made to clarify the acceptability and requirements of real‐world data and real‐world evidence (RWD/E) for the benefit/risk assessment of new medical products in Japan. The objectives of this review were to characterize the use of RWD/E in regulatory applications of new medical products and to describe the ...
Suguru Okami, Kako Shimotsumagari, Yasunari Sadatsuki   +2 more
wiley   +1 more source